Advanced search
Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 76, 2021 - Issue 2
Submit an article Journal homepage
2,903
Views
3
CrossRef citations to date
0
Altmetric
Article

Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia – results from a retrospective Belgian registry study

Stef Meersa Department Oncology, AZ Klina, Brasschaat, Belgium
,
Benjamin Baillyb Department Haematology, Groupe Jolimont, Haine Saint-Paul, BelgiumORCID Iconhttps://orcid.org/0000-0003-0782-2325
ORCID Icon,
Isabelle Vande Broekc Department Oncology, AZ Nikolaas, Haematology, Sint Niklaas, Belgium
,
Bart Malfaitd Department Market Access, Janssen-Cilag NV, Beerse, BelgiumORCID Iconhttps://orcid.org/0000-0002-7940-8521
ORCID Icon,
Sandra Van Hoorenbeeckd Department Market Access, Janssen-Cilag NV, Beerse, Belgium
,
Janice Geersd Department Market Access, Janssen-Cilag NV, Beerse, Belgium
,
Joost Braakmane Department Market Access, Janssen-Cilag BV, Breda, The Netherlands
,
Marieke Van Kouwenhovef Department Medical, Janssen-Cilag BV, Breda, The Netherlands
,
Margaret Doyleg Department Medical, Janssen Ireland, Dublin 24, Ireland
,
Joris Dielsh Department Statistics and Modelling, Janssen Pharmaceutica NV, Beerse, Belgium
,
Karin Caekelberghi Department Real-World Solutions, IQVIA, Zaventem, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1563-2329
ORCID Icon,
Pierre Chevalieri Department Real-World Solutions, IQVIA, Zaventem, Belgium
&
Daan Dierickxj Department Haematology, UZ Leuven, Leuven, BelgiumDepartment Haematology
 show all
Pages 98-105 | Published online: 25 Sep 2019

References

  • Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999 Sep 30;341(14):1051–1062. PubMed PMID: 10502596; eng.
  • Nieto M, Demolis P, Behanzin E, et al. The European medicines agency review of decitabine (dacogen) for the treatment of adult patients with acute myeloid leukemia: summary of the scientific assessment of the committee for medicinal products for human use. Oncologist. 2016 Jun;21(6):692–700. PubMed PMID: 27091416; PubMed Central PMCID: PMCPMC4912358. eng.
  • Visser O, Trama A, Maynadie M, et al. Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer. 2012 Nov;48(17):3257–3266. ( Oxford, England: 1990). PubMed PMID: 22770878; eng.
  • Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematologic malignancies. Ann Oncol. 2007;18:i3–i8.
  • Belgian Cancer Registry 2018. Belgian cancer registry. [cited 15 Dec 2018]. Available from: https://kankerregister.org/
  • De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016 Jul 1;6(7):e441. PubMed PMID: 27367478; PubMed Central PMCID: PMCPMC5030376. eng.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017 Jan 26;129(4):424–447. PubMed PMID: 27895058; PubMed Central PMCID: PMCPMC5291965. eng.
  • Network NCC. NCCN guidelines version 1. 2016 acute myeloid leukemia 2016 [cited 2018 Dec 15]. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx
  • Burnett AK, Milligan D, Prentice AG, et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer. 2007 Mar 15;109(6):1114–1124. PubMed PMID: 17315155; eng.
  • Cashen AF, Schiller GJ, O’Donnell MR, et al. Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol. 2010 Feb 1;28(4):556–561. PubMed PMID: 20026803; eng.
  • Kantarjian HM, Thomas XG, Dmoszynska A, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol. 2012 Jul 20;30(21):2670–2677. PubMed PMID: 22689805; PubMed Central PMCID: PMCPMC4874148. eng.
  • Tawfik B, Sliesoraitis S, Lyerly S. Efficacy of hypomethylating agens as frontline, salvage, or consolidation therapy in adults with acute myeloid leukaemia (AML). Ann Hematol. 2014;93:47–55.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May 19;127(20):2391–2405. PubMed PMID: 27069254; eng.
  • Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005 Oct 15;106(8):2912–2919. PubMed PMID: 15994282; PubMed Central PMCID: PMCPMC1895304. eng.
  • Gavillet M, Noetzli J, Blum S, et al. Transfusion independence and survival in patients with acute myeloïed leukemia treated with 5-azacytidine. Haematologica. 2012;97:1929–1931.
  • Platzbecker U, Hofbauer LC, Ehninger G, et al. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes. Leuk Res. 2012 May;36(5):525–536. PubMed PMID: 22300879; eng.
  • He J, Xiu L, De Porre P, et al. Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia: results from a post hoc analysis of a randomized phase III study. Leuk Lymphoma. 2015 Apr;56(4):1033–1042. PubMed PMID: 25098427; eng.
  • Balducci L. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life. Cancer. 2006 May 15;106(10):2087–2094. PubMed PMID: 16607649; eng.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.